LeMaitre Vascular to Present at Upcoming Investor Conferences

BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it will be participating in seven investor conferences in March.

Steven Chehames, Investor Relations, will participate in the 2018 BTIG Healthcare Conference on Thursday, March 1, 2018 in Snowbird, UT. 

George LeMaitre, Chairman & CEO, is scheduled to present at the 30th Annual ROTH Conference on Tuesday, March 13, 2018 at the Ritz-Carlton Hotel in Laguna Niguel, CA.  The Company’s presentation is scheduled to begin at 10:00 AM PDT.

David Roberts, President, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018 at the Loews Miami Beach Hotel in Miami Beach, FL.  The Company’s presentation is scheduled to begin at 11:15 AM EDT.

JJ Pellegrino, Chief Financial Officer, will participate in the Morgan Stanley Healthcare Corporate Access Day on Tuesday, March 20, 2018 at the Boston Harbor Hotel in Boston, MA.

David Roberts, President, is scheduled to present at the Oppenheimer Annual Healthcare Conference on Wednesday, March 21, 2018 at the Westin New York Grand Central Hotel in New York City.  The Company’s presentation is scheduled to begin at 3:55 PM EDT.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Needham Healthcare Conference on Wednesday, March 28, 2018 at the Westin New York Grand Central Hotel in New York City.  The Company’s presentation is scheduled to begin at 3:30 PM EDT.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Spring Conference on Thursday, March 29, 2018 at the NYC Marriott Marquis Hotel in New York City.  The Company’s presentation is scheduled to begin at 3:50 PM EDT.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Contact:  LeMaitre Vascular, Inc.Investor Relations Steven Chehames+1-781-425-1659[email protected]

Source: LeMaitre Vascular, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
• Needham Starts Horizon Quantum (HQ) at Buy
• ISS and Glass Lewis Recommend FOR Board Declassification Proposal at PENN Entertainment